{"id":91836,"date":"2020-09-09T13:30:31","date_gmt":"2020-09-09T08:00:31","guid":{"rendered":"https:\/\/apnlive.com\/?p=91836"},"modified":"2020-09-09T14:29:15","modified_gmt":"2020-09-09T08:59:15","slug":"russia-asks-india-for-help-in-testing-making-sputnik-v-covid-19-vaccine","status":"publish","type":"post","link":"https:\/\/apnlive.com\/latest-news\/russia-asks-india-for-help-in-testing-making-sputnik-v-covid-19-vaccine\/","title":{"rendered":"Russia asks India for help in testing, making Sputnik-V Covid-19 vaccine"},"content":{"rendered":"\n
Russia has sought India’s help in manufacturing and conducting Phase 3 human trials of its Covid-19 vaccine Sputnik V, the Centre informed on Wednesday.<\/p>\n\n\n\n
Dr V K Paul, Member, NITI Aayog and co-chair, National Expert Group on Vaccine Administration for Covid-19, said three Indian companies had expressed interest in partnering with Moscow-based Gamaleya Research Institute of Epidemiology and Microbiology which has already shared the data of the phase 1 and 2 trials.<\/p>\n\n\n\n
He added that Russia had requested for regulatory mechanisms for Phase 3 trials in India so that the Moscow lab can comply with it and allow for trials. The development comes in the wake of the decision of AstraZeneca to halt trials after a test subject had a side-effect of an unexplained illness. <\/p>\n\n\n\n
The Russian proposal to consider manufacturing through India’s network of pharmaceutical companies will be a fillip to the Make in India project.<\/p>\n\n\n\n